Theruptor novo: wound dressing for diabetic foot ulcer

Abstract

One of the main risk factor affecting the normal wound healing process of is diabetes. India being the capital for diabetes, has a prevalence of 9.6% with 74 million patients living with diabetes and is expected to be 124 million by 2045. The most dreadful complication of diabetes mellitus is the diabetic foot ulcer. Foot ulcer and amputation are among the leading reasons for high morbidity, healthcare costs and mortality in diabetes patients. Numerous things must come together for a chronic wound to heal, and one crucial component of care is the use of wound dressings and these should create an ideal environment for healing while safeguarding the site from infection and additional damage. A diabetic patient presented with a non-healing diabetic foot ulcer (10.83 cm2) with severe loss of protective sensation, exposed excised fourth and fifth metatarsals and he was treated and followed up with regular normal saline washes and Theruptor Novo dressings. The wound started to show signs of healing and within 7 weeks, the wound healed with complete epithelization. Theruptor Novo dressing was helpful in terms of good granulation tissue growth and epithe­lialization over time with good exudate management. Theruptor Novo, a non-adherent dressing with unique antimicrobial action cab be useful in managing diabetic foot ulcers.